220 (PB100) - Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
| Autor: | Wee, S., Ye, M., Lo, Y., Hansbury, M., Shin, N., Weber, M., Roman, V., Huo, L., Skaggs, H., Drake, K., Kapilashrami, K., Stump, K., Yang, J., Chand, S., Timmers, C., Hummel, J., Ye, Y., Zhang, G., Yang, Y.O., Covington, M., Wu, L., Koblish, H., Kim, S. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S79-S79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect